Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients

Schizophrenia Research

Volumn 116, Issue 1, 2010, Pages 90-96

  Rapp, Michael A ^a,b   Schnaider Beeri, Michal ^a   Purohit, Dushyant P ^a   Reichenberg, Abraham ^a,c   McGurk, Susan R ^a   Haroutunian, Vahram ^a,d   Harvey, Philip D ^a,e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Neuropathology; Schizophrenia

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN DISEASE; CLINICAL DEMENTIA RATING SCALE; CORTICAL NEURITIC PLAQUE; DEMENTIA; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENETIC RISK; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; CEREBRAL CORTEX; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; DEMENTIA; FEMALE; GERIATRIC ASSESSMENT; HIPPOCAMPUS; HUMANS; MALE; NEUROFIBRILLARY TANGLES; NEUROPSYCHOLOGICAL TESTS; POSTMORTEM CHANGES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SENILE PLAQUES; SEVERITY OF ILLNESS INDEX;

EID: 71549114521     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.10.013     Document Type: Article

References (42)

1. Akbarian S., Bunney Jr. W.E., Potkin S.G., Wigal S.B., Hagman J.O., Sandman C.A., and Jones E.G. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 50 (1993) 169-177
2. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney Jr. W.E., and Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brain of the schizophrenic patients. Arch. Gen. Psychiatry 53 (1996) 425-436
3. Alzheimer A. Beiträge zur Pathologischen Anatomie der Hirnrinde und zur anatomischen Grundlage der Psychosen. Mschr. Psychiat. Neurol. 2 (1897) 82-112
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition, Revised (1987), American Psychiatric Association, Washington, DC
5. Arnold S.E. Contributions of neuropathology to understanding schizophrenia in late life. Harv. Rev. Psychiatry 9 2 (2001) 69-76
6. Arnold S.E., Franz B.R., and Trojanowski J.Q. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol. Aging 15 (1994) 299-303
7. Baldessarini R.J., Hegarty J.D., Bird E.D., and Benes F.M. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Am. J. Psychiatry 154 6 (1997) 861-863
8. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., and Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48 (1991) 996-1001
9. Benes F.M., Sorensen I., Vincent S.L., Bird E.D., and Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brains. Cereb. Cortex 2 (1992) 503-512
10. Berg L. Clinical Dementia Rating (CDR). Psychopharmacol. Bull. 24 4 (1988) 637-639
11. Bogerts B. The neuropathology of schizophrenic diseases: historical aspects and present knowledge. Eur. Arch. Psychiatry Clin. Neurosci. 249 S4 (1999) 2-13
12. Borenstein Graves A., Mortimer J.A., Bowen J.D., McCormick W.C., McCurry S.M., Schellenberg G.D., and Larson E.B. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology 57 8 (2001) 1453-1460
13. Bruton C.J., Crow T.J., Frith C.D., Johnstone E.C., Owens D.G., and Roberts G.W. Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol. Med. 20 2 (1990) 285-304
14. Buhl L., and Bojsen-Moller M. Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Dan. Med. Bull. 35 (1988) 288-290
15. Buhrich N., Crow T.J., Johnstone E.C., and Owens D.G. Age disorientation in chronic schizophrenia is not associated with pre-morbid intellectual impairment or past physical treatment. Br. J. Psychiatry 152 (1988) 466-469
16. Davidson M., Harvey P.D., Powchik P., Parrella M., White L., Knobler H.Y., Losonczy M.F., Keefe R.S.E., Katz S., and Frecska E. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am. J. Psychiatry 152 (1995) 197-207
17. Dwork A.J., Susser E.S., Keilp J., Waniek C., Liu D., Kaufman M., Zemishlany Z., and Prohovnik I. Senile degeneration and cognitive impairment in chronic schizophrenia. Am. J. Psychiatry 155 (1998) 1536-1543
18. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Psychiatry Res. 12 (1975) 189-198
19. Friedman J.I., Harvey P.D., Coleman T., Moriarty P.J., Bowie C., Parrella M., White L., Adler D., and Davis K.L. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am. J. Psychiatry 158 9 (2001) 1441-1448
20. Gearing M., Mirra S.S., Hedreen J.C., Sumi S.M., Hansen L.A., and Heyman A. The consortium to establish a registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45 3 (1995) 461-466
21. Haroutunian V., Perl D.P., Purohit D.P., Marin D., Khan K., Lantz M., Davis K.L., and Mohs R.C. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch. Neurol. 55 9 (1998) 1185-1191
22. Harvey P.D., Silverman J.M., Mohs R.C., Parrella M., White L., Powchik P., Davidson M., and Davis K.L. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol. Psychiatry 45 1 (1999) 32-40
23. Harvey P.D., Friedman J.I., Bowie C., Reichenberg A., McGurk S.R., Parrella M., White L., and Davis K.L. Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia. J. Clin. Exp. Neuropathol. 28 (2006) 178-192
24. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31 (1990) 545-548
25. Holt D.J., Bachus S.E., Hyde T.M., Wittie M., Herman M.M., Vangel M., Saper C.B., and Kleinman J.E. Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study. Biol. Psychiatry 58 5 (2005) 408-416
26. Johnstone E.C., Owens D.G., Gold A., Crow T.J., and MacMillan J.F. Institutionalization and the defects of schizophrenia. Br. J. Psychiatry 139 (1981) 195-203
27. Karson C.N., Mrak R.E., Husain M.M., and Griffin W.S. Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions. Mol. Chem. Neuropathol. 29 2-3 (1996) 181-191
28. Kay S.R., Opler L.A., and Fiszbein A. Positive and Negative Syndrome Scale (PANSS) manual. Schizophr. Bull. 13 (1987) 261-276
29. Kim K.R., Lee K.S., Kim E.A., Cheong H.K., Oh B.H., and Hong C.H. The effect of the ApoE genotype on the association between head circumference and cognition. Am. J. Geriatr. Psychiatry 16 10 (2008) 819-825
30. Kraepelin E. Dementia praecox and paraphrenia (2002), Thoemmes Press, Bristol
31. Lynch C.A., Walsh C., Blanco A., Moran M., Coen R.F., Walsh J.B., and Lawlor B.A. The Clinical dementia rating sum of box score in mild dementia. Dement. Geriatr. Cogn. Disord. 21 (2006) 40-43
32. Powchik P., Davidson M., Haroutunian V., Gabriel S.M., Purohit D.P., Perl D.P., Harvey P.D., and Davis K.L. Postmortem studies in schizophrenia. Schizophr. Bull. 24 3 (1998) 325-341
33. Prohovnik I., Dwork A.J., Kaufman M.A., and Willson N. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr. Bull. 19 (1993) 805-816
34. Purohit D.P., Davidson M., Perl D.P., Powchik P., Haroutunian V.H., Bierer L.M., McCrystal J., Losonczy M., and Davis K.L. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol. Psychiatry 33 (1993) 255-260
35. Purohit D.P., Perl D.P., Haroutunian V., Powchik P., Davidson M., and Davis K.L. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch. Gen. Psychiatry 55 (1998) 205-211
36. Rapp M.A., Schnaider-Beeri M., Grossman H.T., Sano M., Perl D.P., Purohit D.P., Gorman J.M., and Haroutunian V. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gen. Psychiatry 63 2 (2006) 161-167
37. Reichenberg A., Weiser M., Rabinowitz J., Caspi A., Schmeidler J., Mark M., Kaplan Z., and Davidson M. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am. J. Psychiatry 159 12 (2002) 2027-2035
38. Reichenberg A., Weiser M., Rapp M.A., Rabinowitz J., Caspi A., Schmeidler J., Knobler H.Y., Lubin G., Nahon D., Harvey P.D., and Davidson M. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch. Gen. Psychiatry 62 12 (2005) 1297-1304
39. Religa D., Laudon H., Styczynska M., Winblad B., Naslund J., and Haroutunian V. Amyloid beta pathology in Alzheimer's disease and schizophrenia. Am. J. Psychiatry 60 5 (2003) 867-872
40. Sorbi S., Nacmias B., Tedde A., Latorraca S., Forleo P., Guarnieri B.M., Petruzzi C., Daneluzzo E., Ortenzi L., Piacentini S., and Amaducci L. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. Neurosci. Lett. 244 2 (1998) 118-120
41. Spalletta G., Bernardini S., Bellincampi L., Federici G., Trequattrini A., and Caltagirone C. Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset. Eur. J. Neurol. 13 2 (2006) 176-182
42. Taylor M.A., and Abrams R. Cognitive impairment in schizophrenia. Am. J. Psychiatry 141 (1984) 196-201